Association between village coverage of 13-valent pneumococcal conjugate vaccine and vaccine-type pneumococcal carriage among children aged 0–59 months with pneumonia in Papua New Guinea: an observational study
Background: Pneumococcal conjugate vaccine (PCV) prevents pneumococcal disease and pneumonia, but indirect effects are poorly understood in low-coverage, high-burden settings like Papua New Guinea (PNG). PNG introduced 13-valent PCV (PCV13) in 2014. We aimed to assess direct and indirect effectivene...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2026-06-01
|
| シリーズ: | Vaccine: X |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2590136226000343 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
